U.S. markets closed
  • S&P Futures

    4,347.50
    +29.75 (+0.69%)
     
  • Dow Futures

    34,237.00
    +194.00 (+0.57%)
     
  • Nasdaq Futures

    14,148.50
    +161.75 (+1.16%)
     
  • Russell 2000 Futures

    1,937.20
    +8.90 (+0.46%)
     
  • Crude Oil

    87.00
    +0.39 (+0.45%)
     
  • Gold

    1,797.60
    +4.50 (+0.25%)
     
  • Silver

    22.75
    +0.08 (+0.35%)
     
  • EUR/USD

    1.1156
    +0.0009 (+0.08%)
     
  • 10-Yr Bond

    1.8070
    -0.0410 (-2.22%)
     
  • Vix

    30.49
    -1.47 (-4.60%)
     
  • GBP/USD

    1.3402
    +0.0021 (+0.16%)
     
  • USD/JPY

    115.4000
    +0.0980 (+0.08%)
     
  • BTC-USD

    37,258.32
    +1,070.49 (+2.96%)
     
  • CMC Crypto 200

    844.18
    +24.67 (+3.01%)
     
  • FTSE 100

    7,554.31
    +84.53 (+1.13%)
     
  • Nikkei 225

    26,720.06
    +549.76 (+2.10%)
     

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • JNJ
  • BMY

Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug. Keith Speights: Bristol Myers Squibb and Johnson & Johnson compete head-to-head in the blood thinner market.